These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 26892695

  • 1. Randomized controlled trial comparing 200μg and 400μg sublingual misoprostol for prevention of primary postpartum hemorrhage.
    Ugwu IA, Oluwasola TA, Enabor OO, Anayochukwu-Ugwu NN, Adeyemi AB, Olayemi OO.
    Int J Gynaecol Obstet; 2016 May; 133(2):173-7. PubMed ID: 26892695
    [Abstract] [Full Text] [Related]

  • 2. Double-blind randomized controlled trial comparing misoprostol and oxytocin for management of the third stage of labor in a Nigerian hospital.
    Musa AO, Ijaiya MA, Saidu R, Aboyeji AP, Jimoh AA, Adesina KT, Abdul IF.
    Int J Gynaecol Obstet; 2015 Jun; 129(3):227-30. PubMed ID: 25835642
    [Abstract] [Full Text] [Related]

  • 3. Sublingual misoprostol versus intramuscular oxytocin for prevention of postpartum hemorrhage in low-risk women.
    Chaudhuri P, Biswas J, Mandal A.
    Int J Gynaecol Obstet; 2012 Feb; 116(2):138-42. PubMed ID: 22100204
    [Abstract] [Full Text] [Related]

  • 4. Sublingual misoprostol as an adjunct to oxytocin during cesarean delivery in women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2015 Jan; 128(1):48-52. PubMed ID: 25277789
    [Abstract] [Full Text] [Related]

  • 5. Randomized controlled trial comparing 400μg sublingual misoprostol versus placebo for prevention of primary postpartum hemorrhage.
    Zgaya R, Ghadhab I, Triki MA, Briki R.
    Pan Afr Med J; 2020 Jan; 36():186. PubMed ID: 32952830
    [Abstract] [Full Text] [Related]

  • 6. Sublingual misoprostol versus intravenous oxytocin in prevention of post-partum hemorrhage.
    Tewatia R, Rani S, Srivastav U, Makhija B.
    Arch Gynecol Obstet; 2014 Apr; 289(4):739-42. PubMed ID: 24045979
    [Abstract] [Full Text] [Related]

  • 7. A randomized trial of sublingual misoprostol to augment routine third-stage management among women at risk of postpartum hemorrhage.
    Chaudhuri P, Majumdar A.
    Int J Gynaecol Obstet; 2016 Feb; 132(2):191-5. PubMed ID: 26613819
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A randomised controlled trial of sublingual misoprostol and intramuscular oxytocin for prevention of postpartum haemorrhage.
    Al-Sawaf A, El-Mazny A, Shohayeb A.
    J Obstet Gynaecol; 2013 Apr; 33(3):277-9. PubMed ID: 23550857
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
    Vimala N, Mittal S, Kumar S.
    Int J Gynaecol Obstet; 2006 Feb; 92(2):106-10. PubMed ID: 16343498
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: A randomized clinical trial.
    Othman ER, Fayez MF, El Aal DE, El-Dine Mohamed HS, Abbas AM, Ali MK.
    Taiwan J Obstet Gynecol; 2016 Dec; 55(6):791-795. PubMed ID: 28040121
    [Abstract] [Full Text] [Related]

  • 18. A pilot-randomized comparison of sublingual misoprostol with syntometrine on the blood loss in third stage of labor.
    Lam H, Tang OS, Lee CP, Ho PC.
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):647-50. PubMed ID: 15225189
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.